Coming soon, IMO.
From 2020 Annual Report:
In May 2020, TFS completed the optimisation and production of the improved pilot v2 RUO BARD1 kits and the pilot kits were shipped to our collaborator, University of Geneva (UNIGE), for evaluation. In July 2020, UNIGE commenced studies to evaluate the reproducibility and accuracy of the new pilot v2 RUO BARD1 kits in previously tested ovarian cancer samples. Verification of the accuracy of the v2 RUO BARD1 kits at UNIGE will be an important milestone for the Company, as the BARD1 kits can then be used to further develop and optimise our BARD1 autoantibody tests for early detection of ovarian, breast and lung cancers.
Coming soon, IMO.From 2020 Annual Report:In May 2020, TFS...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |